Medical Device Reprocessing Market by Type (Enzymatic and Non-Enzymatic Detergent), Product and Service (Reprocessing Support & Services and Reprocessed Medical Devices), Devices Type (Critical Devices, Semi-Critical Devices, and Non-Critical Devices), Application (Cardiology, General Study, Orthopedic, Gastroenterology, Urology, and Others), End User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Manufacturers, Ambulatory Surgical Centers, and Others): Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00026024 | Pages: 100 | Industry: Medical Device | Date: Sep 2022 | Type: Global

The market crossed US$ 1.73 billion mark in 2022 and is expected to hit US$ 3.95 billion by 2030, recording a CAGR of 10.1% during the forecast period.

The medical device reprocessing market has been significantly growing with the increase in demand for reprocessed medical devices because of their lower cost.

According to the Association of Medical Device Preprocessors, medical device reprocessing has become one of hospitals' most celebrated supply chain cost reduction strategies. Sterilization and disinfection are essential to ensure that medical instruments and machines do not transmit infectious pathogens to patients, according to the Centers for Disease Control (CDC). Reprocessed medical devices offer reliable patient care, advanced healthcare infrastructure, skilled professionals, and cost-efficient medical procedures that benefit low-income patients. In addition, the cost of the reprocessed device can be nearly half that of new devices. The rise in chronic diseases (cancer, heart disease, stroke, and arthritis) and increasing surgical procedures are expected to nudge future market growth.

Within the report, the market is segmented into type, product and services, device type, application, and geography. By type, the market is bifurcated into enzymatic and non-enzymatic detergent. On the basis of product and service, the market is segmented into reprocessing support & services and reprocessed medical devices. On the basis of device type, the market is segmented into critical, semi-critical, and non-critical devices. Based on application, the market is segmented into cardiology, general study, orthopedic, gastroenterology, urology, and others. By end user, the market is segmented into hospitals, clinics, home healthcare, diagnostic centers, manufacturers, ambulatory surgical centers, and others. Geographically, the market is sub-segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

A catheter reprocessing system ensures the safe reprocessing of catheters and various essential medical devices.

Reprocessing the medical device is a process of cleaning, sterilizing, testing, remanufacturing, disinfecting, and wrapping as well as labeling a used, expired, and undamaged medical device to make it patient-ready at a much-reduced cost. It is a unique process or treatment in preparation for the reuse of medical devices. For diagnosis and treatment purposes, reusable medical devices are used and manufactured for reprocessing and reuse. CRS is an automated system that safely reprocesses medical devices with minimal human intervention, ensuring doctor-patient safety. Therefore, it is a far-reaching technology that will empower the growth of the futuristic market.

Rising adoption of reprocessed devices is the major factor accelerating the market growth.

Reprocessing is a detailed procedure for cleaning, disinfecting, and sterilizing medical equipment. Reprocessed devices are vital for the patient's safety, preventing healthcare-associated infections (HAIs). Reprocessing medical equipment has gained a lot of attention, not just across hospitals but also among the manufacturers who seek it as a means of upping their game and deriving substantial competitive advantage. According to a Fraunhofer Institute for Environmental, Safety, and Energy Technology study, reprocessed electrophysiology (EP) catheters reduce the environmental impact by nearly half matched to a new device. Despite the increasing cost of new technology, the safe and effective reuse of medical devices has become a strategy among hospitals to remain profitable. Clinicians, especially in the electrophysiology and catheterization labs, have relied on medical device reprocessors to save thousands of dollars per device. Other applications such as general study, orthopedic, gastroenterology, urology, and others are also encouraging the use of these reprocessed devices.

Get more information on this report :

Recent strategic developments in the medical device reprocessing market

The medical device reprocessing market has undergone several significant developments, and a few of these have been mentioned below:

  • In May 2019, Medtronic announced U.S. FDA approval and the launch of the Select Site C304-HIS deflectable catheter system. This system is used in procedures involving His-bundle pacing (HBP). This strategic move helped the company generate additional revenue and strengthened its position in the industry.
  • In April 2019, 3M announced that it added 3M expanded wear medical transfer adhesive, 4075 to its line-up of advanced adhesives for medical devices. This has supported the company to expand its product portfolio.
  • In 31st January 2021, Cantel Medical Corp (a global provider of infection prevention) and STERIS announced through a US subsidiary that they had signed a definitive agreement to acquire Cantel.
  • On 25th August 2022, with the launch of ANSI/AAMI ST98:2022, the medical device had a new standard for " clean." The manufacturers have a formalized cleaning validation methodology.

The medical device reprocessing market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Stryker Corporation, Johnson & Johnson, Vanguard AG, Medtronic PLC, Steris Healthcare, Innovative Health, Northeast Scientific, INC., Cardinal Health (Sustainable Technologies), SureTek Medical, and Konoike Group are among the prominent players operating in the market.

The target audience for the report:

  • Venture capitalists, private equity firms, and start-up companies
  • Raw material suppliers
  • End users of medical devices
  • Research institutes, organizations, and consulting companies

Scope of the report:

In this report, the market has been segmented based on:

  • Type:
    • Enzymatic
    • Non-Enzymatic Detergent
  • Product and Services
    • Reprocessing Support and Services
    • Reprocessed Medical Devices
  • Devices Type:
    • Critical Devices
    • Semi-Critical Devices
    • Non-Critical Devices
  • Application
    • Cardiology
    • General study
    • Orthopedic
    • Gastroenterology
    • Urology
    • Others
  • End-user
    • Hospitals
    • Clinics
    • Home Healthcare
    • Diagnostic Centers
    • Manufacturers
    • Ambulatory Surgical Centers
    • Others
  • Region
    • North America
      • US
      • Canada
      • Mexico
    • Europe
  • South & Central America
  • Middle East & Africa
  • Companies profiled
  • Stryker Corporation
  • Johnson & Johnson
  • Vanguard AG
  • Medtronic PLC
  • Steris Healthcare
  • Innovative Health
  • Northeast Scientific, INC.
  • Cardinal Health (Sustainable Technologies)
  • SureTek Medical
  • Konoike Group

Companies profiled
- Stryker Corporation
- Johnson & Johnson
- Vanguard AG
- Medtronic PLC
- Steris Healthcare
- Innovative Health
- Northeast Scientific, INC.
- Cardinal Health (Sustainable Technologies)
- SureTek Medical
- Konoike Group






Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$1500
Site License
$2500
Enterprise License
$3500